It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with beta‐lactams (very low certainty).
It is very uncertain whether fluoroquinolones changes diarrhoea on compared with macrolides (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with macrolides (very low certainty).
It is very uncertain whether fluoroquinolones changes diarrhoea on compared with beta‐lactams (very low certainty).
It is very uncertain whether fluoroquinolones changes relapse ‐ All trials clinical criteria compared with beta‐lactams (very low certainty).
It is very uncertain whether fluoroquinolones changes serious adverse events clinical criteria compared with beta‐lactams (very low certainty).
It is very uncertain whether fluoroquinolones changes adverse events leading to discontinuation of treatment compared with beta‐lactams (very low certainty).